Literature DB >> 10469298

Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1.

P Madsen1, S Anant, H H Rasmussen, P Gromov, H Vorum, J P Dumanski, N Tommerup, J E Collins, C L Wright, I Dunham, A J MacGinnitie, N O Davidson, J E Celis.   

Abstract

Earlier studies of psoriatic and normal primary keratinocytes treated with phorbol 12-myristate-1-acetate identified two low-molecular-weight proteins, termed phorbolin-1 (20 kDa; pI 6.6) and phorbolin-2 (17.6 kDa; pI 6.5). As a first step towards elucidating the role of these proteins in psoriasis, we report here the molecular cloning and chromosomal mapping of phorbolin-1 and a related cDNA that codes for a protein exhibiting a similar amino acid sequence. The phorbolins were mapped to position 22q13 immediately centromeric to the c-sis proto-oncogene. Transient expression of the phorbolin-1 cDNA in COS cells and by in vitro transcription/translation, yielded polypeptides that comigrated with phorbolins-1 and -2. Comparative sequence analysis revealed 22% overall identity and a similarity of 44% of the phorbolins to apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme; however, recombinant-expressed phorbolin-1 exhibited no cytidine deaminase activity, using either a monomeric nucleoside or apolipoprotein B cRNA as substrate, and failed to bind an AU-rich RNA template. Whereas the precise function of the phorbolins remains to be elucidated, the current data suggest that it is unlikely to include a role in the post-transcriptional modification of RNA in a manner analogous to that described for apobec-1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469298     DOI: 10.1046/j.1523-1747.1999.00682.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  22 in total

1.  A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.

Authors:  Heather L Wiegand; Brian P Doehle; Hal P Bogerd; Bryan R Cullen
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

2.  The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers.

Authors:  Brandon Leonard; Jennifer L McCann; Gabriel J Starrett; Leah Kosyakovsky; Elizabeth M Luengas; Amy M Molan; Michael B Burns; Rebecca M McDougle; Peter J Parker; William L Brown; Reuben S Harris
Journal:  Cancer Res       Date:  2015-09-29       Impact factor: 12.701

Review 3.  Powerful mutators lurking in the genome.

Authors:  Vincent Petit; Jean-Pierre Vartanian; Simon Wain-Hobson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-03-12       Impact factor: 6.237

4.  Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities.

Authors:  Yannick Bulliard; Iñigo Narvaiza; Alessandro Bertero; Shyam Peddi; Ute F Röhrig; Millán Ortiz; Vincent Zoete; Nataly Castro-Díaz; Priscilla Turelli; Amalio Telenti; Olivier Michielin; Matthew D Weitzman; Didier Trono
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

5.  C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.

Authors:  Debnath Mukhopadhyay; Shrikant Anant; Robert M Lee; Susan Kennedy; David Viskochil; Nicholas O Davidson
Journal:  Am J Hum Genet       Date:  2001-11-27       Impact factor: 11.025

6.  Identification of the yeast cytidine deaminase CDD1 as an orphan C-->U RNA editase.

Authors:  G S Dance; P Beemiller; Y Yang; D V Mater; I S Mian; H C Smith
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

7.  Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.

Authors:  Beth K Thielen; John P McNevin; M Juliana McElrath; Brook Vander Stoep Hunt; Kevin C Klein; Jaisri R Lingappa
Journal:  J Biol Chem       Date:  2010-07-08       Impact factor: 5.157

8.  Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia.

Authors:  C J Wu; X F Yang; S McLaughlin; D Neuberg; C Canning; B Stein; E P Alyea; R J Soiffer; G Dranoff; J Ritz
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

9.  The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay.

Authors:  Ann Chester; Angelika Somasekaram; Maria Tzimina; Adam Jarmuz; Jane Gisbourne; Raymond O'Keefe; James Scott; Naveenan Navaratnam
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

10.  Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3.

Authors:  Nana Minkah; Kevin Chavez; Parth Shah; Thomas Maccarthy; Hui Chen; Nathaniel Landau; Laurie T Krug
Journal:  Virology       Date:  2014-03-13       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.